Key result
Delta CHA₂DS₂-VASc and delta HAS-BLED scores predict stroke and bleeding more accurately than baseline scores.
Why the study?
The study evaluated whether tracking CHA2DS2-VASc and HAS-BLED scores over time enhances stroke and bleeding risk prediction in atrial fibrillation.
Does dynamic reassessment of CHA₂DS₂-VASc and HAS-BLED scores improve stroke and bleeding risk prediction compared to baseline scores alone in patients with atrial fibrillation?
Cohort (n=529)
Does dynamic reassessment of CHA₂DS₂-VASc and HAS-BLED scores improve stroke and bleeding risk prediction compared to baseline scores alone in patients with atrial fibrillation?
Regular reassessment of CHA₂DS₂-VASc and HAS-BLED scores improves the prediction of stroke and bleeding risks in patients with atrial fibrillation compared to baseline assessment alone.
Answers are grounded in this paper and cite their sources.
May support dynamic CHA₂DS₂-VASc/HAS-BLED reassessment in AF; leaves open impact on decisions without randomized validation.
BACKGROUND AND METHODS: In this prospective longitudinal study-based on data from the Iranian Atrial Fibrillation Registry (IRAF)-patients with available CHA₂DS₂-VASc and HAS-BLED scores at baseline, first follow-up (after 6 months), and second follow-up (after 12 months) were included. Univariable and multivariable logistic regression analyses were performed to evaluate the association of CHA₂DS₂-VASc and HAS-BLED scores (i.e., scores at baseline, first follow-up, and their difference defined as delta) with stroke and bleeding risk, respectively. RESULTS: A total of 529 patients (mean age 61.2 ± 14.3 years; 59.7% male) were included. CHA₂DS₂-VASc and HAS-BLED scores increased significantly after 6 and 12 months from recruitment. delta CHA₂DS₂-VASc score (AUC 0.69; 95% CI: 0.54-0.84) and First follow-up CHA₂DS₂-VASc score (AUC 0.70; 95% CI: 0.51-0.88) achieved higher AUCs compared to baseline CHA₂DS₂-VASc score (AUC 0.63; 95% CI: 0.44-0.82). delta HAS-BLED score had the highest AUC (AUC 0.73; 95% CI: 0.55-0.91) compared to baseline (AUC 0.58; 95% CI: 0.43-0.74) and first follow-up HAS-BLED (AUC 0.60; 95% CI: 0.44-0.80) scores. CONCLUSIONS: Regular reassessment of CHA₂DS₂-VASc and HAS-BLED scores is essential in AF patients, as stroke and bleeding risks change over time, emphasizing the need for dynamic risk stratification.
No takes yet. Share an insight, caveat, or question.
Askarinejad et al. (2025) conducted a cohort in Atrial Fibrillation (n=529). Delta CHA₂DS₂-VASc and HAS-BLED scores vs. Baseline scores was evaluated on Stroke risk prediction (AUC) (AUC, 95% CI 0.54-0.84). Delta CHA₂DS₂-VASc and delta HAS-BLED scores achieved higher predictive accuracy for stroke and bleeding than baseline scores.
Synapse has enriched 10 related papers. Consider them for comparative context: